We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$55.2M
Cap. Flow
+$68.6M
Cap. Flow %
13.33%
Top 10 Hldgs %
9.21%
Holding
1,071
New
432
Increased
168
Reduced
133
Closed
338

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$5.06M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.91M
3
AZO icon
AutoZone
AZO
+$4.44M
4
PSX icon
Phillips 66
PSX
+$4.04M
5
RTX icon
RTX Corp
RTX
+$3.95M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.63M
2
AWK icon
American Water Works
AWK
+$4.76M
3
ROST icon
Ross Stores
ROST
+$4.03M
4
LIN icon
Linde
LIN
+$3.44M
5
AAPL icon
Apple
AAPL
+$3.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.15%
2 Technology 15.58%
3 Industrials 13.47%
4 Financials 11.94%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
401
Tarsus Pharmaceuticals
TARS
$2.84B
$374K 0.07%
+13,761
New +$463K
TD icon
402
Toronto Dominion Bank
TD
$200B
$373K 0.07%
+6,779
New +$384K
VTRS icon
403
Viatris
VTRS
$18.9B
$373K 0.07%
+35,050
New +$387K
PODD icon
404
Insulet
PODD
$9.79B
$372K 0.07%
1,842
-4,606
-71% -$830K
CCJ icon
405
Cameco
CCJ
$42.4B
$371K 0.07%
+7,535
New +$382K
MGRC icon
406
McGrath RentCorp
MGRC
$2.92B
$370K 0.07%
3,477
+1,098
+46% +$121K
AGCO icon
407
AGCO
AGCO
$7.2B
$368K 0.07%
3,760
-2,765
-42% -$308K
RLI icon
408
RLI Corp
RLI
$5.89B
$366K 0.07%
+5,202
New +$372K
PCG icon
409
PG&E
PCG
$38.5B
$365K 0.07%
20,911
-3,281
-14% -$57.8K
XENE icon
410
Xenon Pharmaceuticals
XENE
$6.12B
$364K 0.07%
9,328
+4,465
+92% +$178K
NMRK icon
411
Newmark Group
NMRK
$2.63B
$364K 0.07%
35,536
+1,751
+5% +$17.8K
GOGL
412
DELISTED
Golden Ocean Group
GOGL
$363K 0.07%
26,322
+12,648
+92% +$175K
AMGN icon
413
Amgen
AMGN
$222B
$362K 0.07%
+1,160
New +$341K
KMB icon
414
Kimberly-Clark
KMB
$36.5B
$362K 0.07%
+2,617
New +$350K
SYF icon
415
Synchrony
SYF
$25.6B
$359K 0.07%
+7,598
New +$330K
BASE
416
DELISTED
Couchbase
BASE
$358K 0.07%
+19,604
New +$456K
TCOM icon
417
Trip.com Group
TCOM
$29.1B
$358K 0.07%
7,614
-910
-11% -$46.3K
DEO icon
418
Diageo
DEO
$53.6B
$358K 0.07%
+2,838
New +$391K
CNK icon
419
Cinemark Holdings
CNK
$4.32B
$357K 0.07%
+16,530
New +$300K
DCI icon
420
Donaldson
DCI
$11.4B
$357K 0.07%
+4,983
New +$366K
WH icon
421
Wyndham Hotels & Resorts
WH
$5.48B
$356K 0.07%
+4,813
New +$347K
KMX icon
422
CarMax
KMX
$8.26B
$355K 0.07%
+4,840
New +$349K
RGA icon
423
Reinsurance Group of America
RGA
$16.1B
$355K 0.07%
+1,728
New +$345K
OR icon
424
OR Royalties Inc
OR
$6.2B
$354K 0.07%
+22,699
New +$368K
BCO icon
425
Brink's
BCO
$4.62B
$354K 0.07%
+3,454
New +$329K
15 16
17
18 19

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Aigen Investment Management held 1,071 positions worth $514M, up 12% from $459M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Aigen Investment Management deployed $68.6M of net new capital in Q2 2024, opening 432 new positions and adding to 168 existing holdings. Its largest new stake was Visa: 18,454 shares worth $4.84M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hess, an estimated $2.91M trimmed.

  • Aigen Investment Management's largest Q2 2024 buy was Visa: 18,454 shares worth $4.84M.
  • Aigen Investment Management added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.91M increase.
  • Aigen Investment Management's biggest Q2 2024 reduction was Hess, cutting an estimated $2.91M.
  • Aigen Investment Management fully exited Eli Lilly in Q2 2024, selling an estimated $6.63M.
  • Aigen Investment Management's ten largest holdings make up 9.2% of its $514M portfolio in Q2 2024.
  • Aigen Investment Management opened 432 new positions and closed 338 in Q2 2024.
  • Aigen Investment Management's portfolio value rose 12% quarter-over-quarter to $514M.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.